Skip to main content
Jishu Das, MD, Internal Medicine, Columbus, OH

JishuKingkarDasMD

Internal Medicine Columbus, OH

Hospital Medicine/Hospitalist

Physician

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Das' full profile

Already have an account?

  • Office

    410 W 10th Ave
    Columbus, OH 43210
    Phone+1 614-293-7499
    Fax+1 614-366-2360

Summary

  • I am a board certified Internal Medicine hospitalist. I have 7 years of experience working in tertiary care hospitals taking care of complex patients from diverse backgrounds. I am looking for either a full time hospitalist or a traditional clinic practice with in- hospital or ER time.

Education & Training

  • Western Michigan University Homer Stryker MD School of Medicine
    Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 2009 - 2012
  • Guwahati Medical College
    Guwahati Medical CollegeClass of 1999

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2016 - 2025
  • TX State Medical License
    TX State Medical License 2015 - 2025
  • IN State Medical License
    IN State Medical License 2012 - 2017
  • MI State Medical License
    MI State Medical License 2009 - 2013
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Journal Articles

  • Incidence of Ototoxicity in Head and Neck Cancer (HNSCC) Patients (pts) Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Triweekly Cisplatin (Cis)  
    Das J, Custer A, Blakaj D, Old M, Songzhu Z, Bhatt A, Kang S, Agrawal A, Ozer E, Wobb J, Rupert R, Mitchell D, Brock G, Verschraegen C, Rocco J, Bonomi M, J Clin Oncol, 1/1/2018
  • Clinical and immune effects of cetuximab and weekly low dose carboplatin and paclitaxel in head and neck cancer patients with poor performance status  
    Marcelo Raul Bonomi, Brett Klamer, Tamjeed Ahmed, Safoa Ado, Mitra Kooshki, Jishu Das, Guy Brock, Triozzi Pierre, J Clin Oncol, 1/1/2018

Books/Book Chapters

Abstracts/Posters

  • Incidence of Ototoxicity in Head and Neck Cancer (HNSCC) Patients (pts) Receiving Concomitant Chemo-Radiation (CRT) with Weekly or Triweekly Cisplatin (Cis).
    Das J, Custer A, Blakaj D, Old M, Songzhu Z, Bhatt A, Kang S, Agrawal A, Ozer E, Wobb J, Rupert R, Mitchell D, Brock G, Verschraegen C, Rocco J, Bonomi M, American Society of Clinical Oncology Annual Meeting, 1/1/2018

Lectures

  • Incidence of ototoxicity in head and neck cancer (HNSCC) patients (pts) receiving concomitant chemo-radiation (CRT) with weekly or triweekly cisplatin (Cis). 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018